tiprankstipranks
Art'S-Way Manufacturing Co. (ARTW)
NASDAQ:ARTW
Want to see ARTW full AI Analyst Report?

Art's-Way Manufacturing Co (ARTW) AI Stock Analysis

142 Followers

Top Page

ARTW

Art's-Way Manufacturing Co

(NASDAQ:ARTW)

Select Model
Select Model
Select Model
Neutral 45 (OpenAI - 5.2)
Rating:45Neutral
Price Target:
$2.00
▼(-15.97% Downside)
Action:Reiterated
Date:08/11/26
The score is held down primarily by weak cash flow and deteriorating profitability, reinforced by bearish technical signals and limited valuation support due to losses. The improving balance sheet and the major modular-building contract/backlog expansion provide a meaningful offset but do not fully counter the current earnings and cash-generation weakness.
Positive Factors
Modular backlog expansion
A >$19M modular-buildings backlog materially raises multi-quarter revenue visibility and factory utilization, supporting sustained production activity. If executed, these contracts can stabilize top-line flows, improve fixed-cost absorption and enhance near-term earnings potential.
Negative Factors
Weak cash generation
Persistent negative operating and free cash flow indicate earnings do not convert reliably to cash, forcing reliance on financing or equity to fund operations. Over months this limits reinvestment capacity, raises liquidity risk, and constrains ability to scale modular production without external funding.
Read all positive and negative factors
Positive Factors
Negative Factors
Modular backlog expansion
A >$19M modular-buildings backlog materially raises multi-quarter revenue visibility and factory utilization, supporting sustained production activity. If executed, these contracts can stabilize top-line flows, improve fixed-cost absorption and enhance near-term earnings potential.
Read all positive factors

Art's-Way Manufacturing Co (ARTW) vs. SPDR S&P 500 ETF (SPY)

Art's-Way Manufacturing Co Business Overview & Revenue Model

Company Description
Art's-Way Manufacturing Co., Inc. manufactures and sells agricultural equipment, and specialized modular science and agricultural buildings in the United States and internationally. It operates through two segments, Agricultural Products and Modul...
How the Company Makes Money
Art's-Way makes money by manufacturing and selling equipment and related parts/services across its operating segments. Revenue is primarily generated from (1) sales of agricultural machinery and equipment to a dealer network and end customers, wit...

Art's-Way Manufacturing Co Financial Statement Overview

Summary
Financials are mixed but pressured overall: revenue rebounded (+6.2%) and leverage is improving (debt-to-equity ~0.31), yet profitability deteriorated to near-breakeven/negative and cash generation is materially weak with negative operating cash flow and free cash flow.
Income Statement
48
Neutral
Balance Sheet
63
Positive
Cash Flow
28
Negative
BreakdownTTMNov 2025Nov 2024Nov 2023Nov 2022Nov 2021
Income Statement
Total Revenue25.99M22.98M24.50M30.28M25.65M24.97M
Gross Profit6.57M5.92M7.31M8.58M6.94M6.60M
EBITDA1.13M2.60M1.45M2.48M1.51M1.19M
Net Income-21.83K1.03M307.38K266.97K97.80K212.63K
Balance Sheet
Total Assets23.68M22.48M21.24M24.40M23.95M20.85M
Cash, Cash Equivalents and Short-Term Investments5.97K4.85K1.86K4.01K5.05K2.66K
Total Debt6.44M6.41M4.78M8.15M7.40M7.04M
Total Liabilities9.87M9.17M9.15M12.76M12.80M10.50M
Stockholders Equity13.80M13.31M12.09M11.64M11.15M10.35M
Cash Flow
Free Cash Flow-2.58M-1.53M1.90M-896.98K-717.76K-1.61M
Operating Cash Flow-1.65M-904.14K2.63M-55.19K951.72K-985.85K
Investing Cash Flow-797.83K-580.48K961.07K-453.51K-1.34M-599.48K
Financing Cash Flow2.45M1.49M-3.59M507.67K394.52K1.59M

Art's-Way Manufacturing Co Risk Analysis

Art's-Way Manufacturing Co disclosed 2 risk factors in its most recent earnings report. Art's-Way Manufacturing Co reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 1 New Risks

Art's-Way Manufacturing Co Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
68
Neutral
$263.84M15.527.08%-6.39%-1.99%
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
48
Neutral
$8.58M-0.02-500.33%-30.80%-317.49%
48
Neutral
$35.39M-1.29-86.90%-26.88%72.36%
45
Neutral
$14.88M-354.55-0.16%10.50%-101.58%
45
Neutral
$48.43M-2.01-56.92%665.00%65.65%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
ARTW
Art's-Way Manufacturing Co
3.12
-1.13
-26.59%
GENC
Gencor
18.00
2.76
18.11%
HYFM
Hydrofarm Holdings Group
1.47
-3.04
-67.41%
XOS
Xos
2.10
-1.16
-35.74%
RYM
RYTHM
20.80
-9.68
-31.76%

Art's-Way Manufacturing Co Corporate Events

Business Operations and StrategyFinancial Disclosures
Art’s-Way Manufacturing Secures Major Modular Building Contracts
Positive
Aug 10, 2026
On August 10, 2026, Art’s-Way announced that its Modular Buildings segment had recently secured major contracts, lifting the segment’s backlog to over $19.0 million from the $1.3 million reported for the fiscal quarter ended May 31, 20...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 11, 2026